Skip to main content
Elsevier
Shopping Cart
openUserAccount

Radiotherapy & Oncology

  • ISSN: 0167-8140

Editor-In-Chief: Baumann

Next planned ship date: November 21, 2023

  • 5 Year impact factor: 5.8
  • Impact factor: 5.7

Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes:… Read more

Image - Radiotherapy & Oncology
Subscription options

Subscription options

Next planned ship date:
November 21, 2023

Institutional subscription on ScienceDirect

Request a sales quote
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology. Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published. Editorial Office:Professor Michael Baumann, Editor-in-Chief, Radiotherapy and Oncology Editorial Office, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany (email: [email protected]).